Your browser doesn't support javascript.
loading
Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors.
Verdura, Sara; Encinar, Jose Antonio; Teixidor, Eduard; Segura-Carretero, Antonio; Micol, Vicente; Cuyàs, Elisabet; Bosch-Barrera, Joaquim; Menendez, Javier A.
Afiliación
  • Verdura S; Metabolism and Cancer Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, 17005 Girona, Spain.
  • Encinar JA; Girona Biomedical Research Institute, Salt, 17190 Girona, Spain.
  • Teixidor E; Institute of Research, Development and Innovation in Biotechnology of Elche (IDiBE) and Molecular and Cell Biology Institute (IBMC), Miguel Hernández University (UMH), 03202 Elche, Spain.
  • Segura-Carretero A; Girona Biomedical Research Institute, Salt, 17190 Girona, Spain.
  • Micol V; Medical Oncology, Catalan Institute of Oncology, 17007 Girona, Spain.
  • Cuyàs E; Department of Analytical Chemistry, University of Granada, 18071 Granada, Spain.
  • Bosch-Barrera J; Institute of Research, Development and Innovation in Biotechnology of Elche (IDiBE) and Molecular and Cell Biology Institute (IBMC), Miguel Hernández University (UMH), 03202 Elche, Spain.
  • Menendez JA; CIBEROBN (Physiopathology of Obesity and Nutrition CB12/03/30038) Carlos III Health Institute, 28029 Madrid, Spain.
Cancers (Basel) ; 14(24)2022 Dec 11.
Article en En | MEDLINE | ID: mdl-36551587
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: España